Progesterone in Menopause: What It Does and Why You Need It

In menopause hormone therapy, progesterone's primary role is to protect the lining of your uterus (the endometrium) from estrogen. Estrogen stimulates that lining to thicken; without something to balance it, the tissue can overgrow—a condition called endometrial hyperplasia that can progress to endometrial cancer. Progesterone counteracts this by keeping the lining thin and stable.

This is why hormone therapy is often called “estrogen plus progesterone” for women who have a uterus. The estrogen treats your symptoms—hot flashes, night sweats, vaginal dryness, mood—while the progesterone is the safety component that makes taking estrogen safe for your uterus. It is not optional; it is protective.

Progesterone (or its lab-made cousins, progestins) can be taken as a daily pill, on a cyclical schedule that produces a monthly bleed, or delivered locally through a hormonal IUD. The delivery matters less than the fact that you get enough of it to oppose the estrogen. For a broader look at how estrogen delivery is chosen, see our guide to [HRT patch vs pill vs gel](/blog/hrt-patch-vs-pill-vs-gel-which-is-safest). Understanding progesterone's protective job is the foundation for every other decision about your regimen.

If you have had a hysterectomy and no longer have a uterus, you generally do not need progesterone—you can take estrogen alone. Because progesterone's main purpose in hormone therapy is to protect the endometrium, and there is no endometrium to protect, most guidelines say estrogen-only therapy is appropriate.

This distinction matters because estrogen-only therapy has a different, and in some ways more favorable, risk profile than combined therapy. In the Women's Health Initiative (WHI), the estrogen-alone arm did not show the increased breast cancer signal seen in the estrogen-plus-progestin arm; some analyses even suggested a neutral or slightly reduced breast cancer risk over long follow-up. So avoiding unnecessary progesterone is a genuine benefit for women without a uterus.

There are a few exceptions. Some clinicians add progesterone for women who have had endometriosis (in case residual endometrial tissue remains) or occasionally for its sleep and mood benefits, though the latter is an off-label, individualized decision. The general rule stands: uterus = you need progesterone; no uterus = usually estrogen alone. Always confirm with your prescriber, since your surgical and personal history can change the calculation.

The key difference is that micronized progesterone is body-identical—structurally the same as the progesterone your ovaries made—while synthetic progestins are chemically altered molecules that act on progesterone receptors but are not identical. This distinction affects both how you feel and your risk profile.

Micronized progesterone, sold as Prometrium or Utrogestan, is derived from plant sources and processed into a form the body recognizes as its own. Older synthetic progestins, such as medroxyprogesterone acetate (the progestin used in the WHI combined arm) or norethisterone, are effective at protecting the uterus but behave slightly differently in other tissues.

That difference appears to matter for breast health. Large observational studies, including French cohort research, found that hormone therapy using micronized progesterone was associated with a lower breast cancer risk than regimens using synthetic progestins, at least in the first several years of use. Micronized progesterone also tends to have fewer bothersome side effects like bloating and mood changes. For these reasons, most menopause specialists now prefer micronized progesterone as first-line. This body-identical distinction is closely related to the debate we cover in [bioidentical vs synthetic HRT](/blog/bioidentical-vs-synthetic-hrt-whats-the-difference).

Yes—micronized progesterone often improves sleep, which is one reason clinicians usually recommend taking it at bedtime. When progesterone is broken down by the body, it produces metabolites (such as allopregnanolone) that act on GABA receptors, the same calming brain system targeted by many anti-anxiety and sleep medications. The result is a mild sedative effect for many women.

This is a meaningful bonus, because sleep disruption is one of the most common and draining symptoms of menopause. Between night sweats, anxiety, and the direct effects of declining hormones, many women struggle to sleep through the night. Taking oral micronized progesterone before bed can make falling and staying asleep easier, addressing a symptom and delivering the uterine protection in one dose.

A few caveats: the sedative effect is specific to oral micronized progesterone—synthetic progestins and non-oral delivery (like the hormonal IUD) do not reliably produce it. Some women feel groggy the next morning, which is usually solved by taking it earlier in the evening. And progesterone is not a standalone sleep aid; it is part of a hormone regimen. Still, for women who need both endometrial protection and better rest, this dual benefit is a genuine advantage worth discussing with your prescriber.

The most common side effects of progesterone in hormone therapy are drowsiness, breast tenderness, bloating, and mood changes, and they are generally milder with micronized progesterone than with older synthetic progestins. Most side effects ease over the first few weeks or improve with a change in dose, timing, or delivery method.

The drowsiness is usually a feature rather than a bug when the pill is taken at night. Breast tenderness and bloating tend to be dose-dependent. Some women—particularly those sensitive to hormonal shifts—notice low mood or irritability on certain progestogens; switching from a synthetic progestin to micronized progesterone, or adjusting the schedule, often resolves it.

The more important consideration is the breast cancer risk associated with the progestogen component of combined HRT. The WHI linked estrogen plus a synthetic progestin to a small increase in breast cancer risk with longer use, while micronized progesterone appears lower-risk. In absolute terms the added risk is modest, and it must be weighed against HRT's benefits for symptoms, bone density, and quality of life—a personal calculation best made with a knowledgeable clinician. If you are also managing weight or metabolic changes alongside menopause, Lea can help you organize your questions before your appointment so you get the regimen that fits you.